The QualityStocks Daily Wednesday, March 15th, 2023

Today's Top 3 Investment Newsletters

QualityStocks(THMO) $4.1900 +98.58%

MarketClub Analysis(TTCM) $0.0014 +55.56%

360wallstreet(JNCE) $1.4900 +40.57%

The QualityStocks Daily Stock List

Aslan Pharmaceuticals (ASLN)

TradersPro, StockMarketWatch, QualityStocks, MarketBeat, BUYINS.NET, Schaeffer's, MarketClub Analysis and InvestorsUnderground reported earlier on Aslan Pharmaceuticals (ASLN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aslan Pharmaceuticals Limited (NASDAQ: ASLN) (FRA: 7A9) is a clinical-stage biopharmaceutical firm focused on immunology, which is centered on the development of treatments of novel therapies.

The firm has its headquarters in Singapore and was incorporated in 2010 by Jeffrey Tomlinson, Mark McHale and Carl Aslan Jason Morton Firth. It operates in the health care sector under the biotech and pharma sub-industry. The firm targets ailments that are prevalent in Asia and orphan indications in Europe and the United States.

The company is party to a joint venture with Bukwang Pharmaceutical Co. Ltd, which entails the development of immune-oncology therapeutics that target the AhR pathway. It also has partners, which include CSL Limited, Array BioPharma and Almirall, and is focused on developing therapies that transform the lives of patients.

The enterprise’s pipeline is made up of a first-in-class monoclonal therapy dubbed ASLAN004 which is indicated for the treatment of atopic dermatitis and asthma, among other immunology indications. Atopic dermatitis, commonly known as eczema, makes an individual’s skin itchy and red. On the other hand, asthma causes a patient’s airways to swell and narrow, which makes it harder to breathe and results in coughing or wheezing. In addition to this, it also develops a small-molecule dihydroorotate dehydrogenase inhibitor known as ASLAN003, indicated for the treatment of various autoimmune conditions. Furthermore, the enterprise also produces an AhR antagonist and varlitinib.

The company’s ASLAN004 formulation, which recently concluded its phase 1 study and is set to proceed to phase 2, has shown remarkable effectiveness and safety. Its success will benefit patients with atopic dermatitis and bring in more investors into the firm, which will be good for the company’s growth.

Aslan Pharmaceuticals (ASLN), closed Wednesday's trading session at $3.2, up 15.1079%, on 98,231 volume. The average volume for the last 3 months is 30.554M and the stock's 52-week low/high is $2.3501/$24.724975.

ThermoGenesis Holdings (THMO)

BUYINS.NET, StockMarketWatch, QualityStocks, StocksEarning and MarketClub Analysis reported earlier on ThermoGenesis Holdings (THMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ThermoGenesis Holdings Inc. (NASDAQ: THMO) (FRA: THRP) is a healthcare firm that is focused on the development, commercialization and marketing of various automated technologies for CAR-T therapies as well as other cell-based therapies.

The firm has its headquarters in Rancho Cordova, California and was incorporated in 1986 by Philip H. Coelho and David Demirjian. Prior to its name change in November 2019, the firm was known as Cesca Therapeutics Inc. It operates as part of the healthcare/life sciences sector and serves consumers around the globe.

The company operates through the clinical development and device segments. The former segment uses autologous stem cell-based therapeutics while the latter segment is involved in developing and commercializing automated technologies for bioprocessing and cell-based therapeutics.

The enterprise manufactures and markets an automated cryogenic storage and liquid nitrogen controlled-rate-freezing system dubbed the BioArchive Automated Cryopreservation system, which has been designed for cord blood samples and cell therapeutics with clinical applications; and an automated cell separation system known as the AXP II Automated Cell separation system, which isolates and retrieves stem and progenitor cells from blood in the umbilical cord. It also provides a sterile automated system dubbed the PXP point-of-care system, which has been designed to process autologous bone marrow aspirate extracted from stem cells at point-of-care, like in clinics or surgical centers.

The company is focused on pivoting from a device-only firm into a firm that provides the industry with cell-based contract development and manufacturing services. This is in addition to expanding its line of automated cell processing tools.

ThermoGenesis Holdings (THMO), closed Wednesday's trading session at $4.19, up 98.5782%, on 30,554,240 volume. The average volume for the last 3 months is 490,623 and the stock's 52-week low/high is $0.075/$5.55.

CYNGN Inc. (CYN)

The Street, MarketClub Analysis, QualityStocks, StreetInsider, The Tycoon Report, The Trading Report, Money Morning, INO.com Market Report, InvestorPlace, MarketBeat, Money and Markets, AllPennyStocks, Street Insider, Zacks, The Stock Enthusiast, TradingAuthority Daily and SmarTrend Newsletters reported earlier on CYNGN Inc. (CYN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CYNGN, Inc. (NASDAQ: CYN) is an AV (autonomous vehicle) technology firm which is engaged in the development of autonomous driving software for industrial and commercial machines.

The firm has its headquarters in Menlo Park, California and was incorporated in 2013. Prior to its name change, the firm was known as Cyanogen Inc. It operates as part of the computer systems design and related services industry, under the technology sector. The firm serves consumers in the United States.

The company’s platform uses machine learning, sensor fusion and computer vision to empower vehicles to adjust to complex environments, learn and share, which transforms them into self-driving and fully-integrated fleets of the future.

The enterprise is developing an internal tool suite and infrastructure dubbed CyngnEvolvem which facilitates machine learning and artificial intelligence training to improve models and algorithms. It also offers a simulation framework which ensures that the data gathered in the field can be applied to new releases. It also develops a customer facing tool suite for managing and monitoring autonomous vehicle fleets dubbed Cyngn Insight. This tool also aggregates and analyzes data. In addition to this, the enterprise develops a modular industrial vehicle autonomous driving software known as DriveMod.

The firm recently launched a turnkey autonomous vehicle solution known as the DriveMod Kit for the Stockchaser vehicles. This move creates opportunity for the adoption of the firm’s turnkey solutions for both new and retrofit vehicles, which will help extend its consumer reach and bring in additional revenues.

CYNGN Inc. (CYN), closed Wednesday's trading session at $1.14, up 14%, on 490,623 volume. The average volume for the last 3 months is 300,116 and the stock's 52-week low/high is $0.5824/$6.25.

Freightos (CRGO)

Stock Traders Chat, OTCPicks, The Stock Dork and MarketBeat reported earlier on Freightos (CRGO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Freightos Limited (NASDAQ: CRGO) is a vendor-neutral booking and payment platform for global freight.

The firm has its headquarters in Jerusalem, Israel. Prior to its name change, the firm was known as Gesher I Acquisition Corp. It operates as part of the integrated freight and logistics industry, under the industrials sector. The firm serves consumers around the globe.

The company is focused on making global shipping faster, more cost-effective and reliable, in an effort to expand trade between individuals around the world. It operates through the following business units: WebCargo, Freightos.com and Freightos Data. Freightos Data publishes the Freightos Baltic Index (FBX), which provides container shipping prices as well as other data products.

The enterprise’s offerings include WebCargo, a global freight platform connecting carriers and forwarders in particular and an air cargo e-Booking platform; and Freightos.com, a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. It also provides software-as-a-service solutions, WebCargo AcceleRate, a multi-modal rate repository; WebCargo Air for airline rates and ebookings; data services; and WebCargo Airline Control Panel that enables airlines to control bookings and optimize pricing with real-time booking analytics. In addition, the enterprise offers digital customs brokerage services; and operates 7LFreight, a neutral and centralized rate management platform.

The firm, which is set to announce its latest financial results, recently collaborated with JetBlue Cargo to help move air cargo efficiently and competitively. This will generate additional revenues for the firm while also opening it up to new growth and investment opportunities.

Freightos (CRGO), closed Wednesday's trading session at $3.99, off by 0.992556%, on 300,138 volume. The average volume for the last 3 months is 11,244 and the stock's 52-week low/high is $3.48/$31.15.

H2O Innovation (HEOFF)

MarketBeat, InvestorIntel, Trades Of The Day, TradersPro, InvestorPlace and Daily Trade Alert reported earlier on H2O Innovation (HEOFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

H2O Innovation Inc. (OTCQX: HEOFF) (TSE: HEO) (FRA: H301) (EPA: ALHEO) is a company focused on designing and providing integrated water treatment solutions based on membrane filtration technology.

The firm has its headquarters in Quebec City, Canada and was incorporated in 1995, on August 23rd by Frederic Dugre. It operates as part of the utilities-regulated water industry, under the utilities sector. The firm primarily serves consumers in Canada.

The enterprise operates through the Water Technologies and Services, Specialty Products, and Operation and Maintenance Services segments. It provides membrane filtration technology for municipal, industrial, energy, and natural resources end-users; and aftersales services, as well as digital solutions to monitor and optimize water treatment plants. Its products include the FiberFlex open-source technologies for water treatment systems; and the flexMBR for wastewater treatment systems. The enterprise also provides specialty chemicals, consumables, and specialized products for the water industry, including reverse osmosis (RO) membrane chemicals, such as flocculants, antiscalants, biocides, and cleaning chemicals; corrosion resistant equipment for desalination plants; flexible grooved-end couplings, fiberglass reinforced polyester (FRP) cartridge filter housings, self-cleaning disc and screen filters, bag filters, cartridges, and strainers; and maple equipment and products. In addition to this, it operates, maintains, and repairs water and wastewater treatment systems, distribution equipment, and associated assets.

The company, in collaboration with Fox City Brewing, has developed a beer using purified recycled water dubbed Revival Lager. This move will generate additional revenues for the company while also increasing awareness and public acceptance of potable water reuse.

H2O Innovation (HEOFF), closed Wednesday's trading session at $1.827, off by 6.3077%, on 11,244 volume. The average volume for the last 3 months is 50 and the stock's 52-week low/high is $1.2301/$2.18.

Naples Soap (NASO)

We reported earlier on Naples Soap (NASO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Naples Soap Company Inc. (OTC: NASO) is a health and wellness firm that is involved in manufacturing and selling personal care products.

The firm has its headquarters in Fort Myers, Florida and was incorporated in 2006, on July 6th. Prior to its name change in May 2022, the firm was known as The GNS Group Inc. It operates as part of the household and personal products industry, under the consumer defensive sector. The firm serves consumers in the United States, with a focus on those in the state of Florida.

The company was founded by Deanna Wallin, a former nurse. Her objective was to help others struggling with psoriasis and eczema using natural and organic products.

The enterprise’s personal care products are made in the USA with premium, high-quality, natural and organic ingredients. They include scents, soaps, butter and scrubs, conditioner bars, moisturizers, toners, body oil and facial rollers, among other products. It operates 10 retail locations in Florida; Destin, Estero, Fort Myers, Mt. Dora, Naples, Punta, Gorda, Sanibel, Lakewood Ranch, Kissimmee and South Naples. The enterprise also sells its products through its naplessoap.com website. This is in addition to providing its products on wholesale to more than 300 national and boutique re-sellers and working with DTC (direct-to-consumer) sites including Amazon and Faire.

The company recently reopened 2 stores in Naples and one in Fort Myers, which had flooded as a result of Hurricane Ian. This will positively influence its revenues while also meeting consumer needs.

Naples Soap (NASO), closed Wednesday's trading session at $0.16, even for the day, on 50 volume. The average volume for the last 3 months is 98,302 and the stock's 52-week low/high is $N/A/$N/A.

Galaxy Digital (BRPHF)

TradersPro, The Street, MarketBeat and InvestorPlace reported earlier on Galaxy Digital (BRPHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Galaxy Digital Holdings Ltd (OTC: BRPHF) (TSE: GLXY) (FRA: 7LX) (BMV: GLXYN) is a financial services and investment management firm that is involved in the digital asset, cryptocurrency, and block chain technology industry.

The firm has its headquarters in New York and was incorporated in 2006, on February 10th by Michael Edward Novogratz. It operates as part of the capital markets industry, under the financial services sector. The firm serves consumers around the globe.

The enterprise operates through the Trading, Principal Investments, Asset Management, Investment Banking and Mining segments. It offers spot, derivate, and financing liquidity to institutional clients, counterparties, and venues that transact in cryptocurrencies and other digital assets. It also provides access to traded cryptocurrencies to clients and counterparties across a suite of service offerings, including over-the-counter (OTC) spot liquidity provision, on- exchange liquidity provision, OTC options and trading, and bespoke lending and structured products, as well as engages in the proprietary quantitative, arbitrage, and macro trading strategies. The enterprise also manages third-party capital across traditional and alternative asset classes. In addition to this, it provides financial advisory services, such as general corporate, strategic, mergers and acquisitions, divestitures, and restructuring advisory services, as well as equity, debt, and project finance capital markets services to public and private clients. Further, it has a strategic focus to provide financial tools to North American miners, as well as has partnerships with third-party data center providers and hosts its proprietary bitcoin mining equipment for helping to secure the Bitcoin network.

The firm recently finalized its acquisition of GK8, a secure institutional digital asset custody platform. This will improve how its clients interact with and store digital assets while also generating additional revenues for the firm.

Galaxy Digital (BRPHF), closed Wednesday's trading session at $3.065, off by 7.1212%, on 98,377 volume. The average volume for the last 3 months is 10 and the stock's 52-week low/high is $2.43/$22.06.

Sagicor Financial (SGCFF)

We reported earlier on Sagicor Financial (SGCFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sagicor Financial Company Limited (OTC: SGCFF) (TSE: SFC) is a financial and insurance firm that is engaged in the provision insurance products and related financial services.

The firm has its headquarters in St. Michael, Barbados and was incorporated in 2017, on February 8th by Donald J. Walker, Vince John Hemmer, Helmut Swarovski, Azim Jamal, Joseph M. Natale, Nadir H. Mohamed, Lee Lau and Anthony Lacavera. It operates as part of the insurance-life industry, under the financial services sector. The firm serves consumers in the United States and the Caribbean.

The enterprise operates through the Sagicor Jamaica, Sagicor Life and Sagicor USA segments. The Sagicor Life segment offers life, health insurance, property and casualty insurance, pensions, annuities, and asset management services in Trinidad and Tobago, Barbados, Eastern Caribbean, Dutch Caribbean, the Bahamas and Central America. The Sagicor Jamaica segment provides life, health, annuity, property and casualty insurance, pension administration services, commercial banking, investment banking, hospitality and real estate investment services in the markets of Jamaica, Cayman Islands, Costa Rica and the United States. On the other hand, the Sagicor Life USA segment offers life and annuity products to middle market America through independent producers. Its products include Periodic premium, Single premium life and Annuities.

The company recently appointed a new Chief Financial Officer who has a deep understanding of the financial services industry as well as a new Executive VP of Corporate Development and Capital Markets. These moves will contribute to the company’s growth greatly and help create shareholder value.

Sagicor Financial (SGCFF), closed Wednesday's trading session at $3.6, even for the day. The average volume for the last 3 months is 2.405M and the stock's 52-week low/high is $3.60/$6.00.

Southern Copper Corporation (SCCO)

MarketBeat, SmarTrend Newsletters, InvestorPlace, The Street, Louis Navellier, The Online Investor, QualityStocks, Daily Wealth, Daily Trade Alert, TopStockAnalysts, The Wealth Report, Trades Of The Day, StreetAuthority Daily, Zacks, Marketbeat.com, Barchart, Money Morning, TheStockAdvisor, Early Bird, Kiplinger Today, Market Intelligence Center Alert, Schaeffer's, MarketClub Analysis, Top Pros' Top Picks, Market Authority, The Growth Stock Wire, Uncommon Wisdom, Investopedia, StreetInsider, TheStockAdvisors, ChartAdvisor, INO.com Market Report, Investment House, The Stock Enthusiast, Investiv, InvestmentHouse, Investing Futures, Greenbackers, Forbes, DrStockPick, Dividend Opportunities, CRWEWallStreet, CRWEPicks, CRWEFinance, Cabot Wealth, BestOtc, AllPennyStocks, DividendStocks, StockHotTips, Wealth Insider Alert, Wealth Daily, Vantage Wire, TradingMarkets, TradingAuthority Daily, The Tycoon Report, The Trading Report, The Motley Fool, Streetwise Reports, MarketDNA, StockLockandLoad, Investor Update, Profit Confidential, PennyToBuck, PennyOmega, Navellier Growth, Money and Markets, 24/7 Trader, InvestorsObserver Team, InvestorIntel, InvestorGuide and StockRockandRoll reported earlier on Southern Copper Corporation (SCCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Copper prices went down by 0.2% last week amid hawkish comments from the chair of the US Federal Reserve. Even though projections from late 2022 and early 2023 suggested that inflation levels would be lower this year, Fed chair Jerome Powell said during a recent interview that the U.S. central bank would most likely raise interest rates higher than expected to combat rising inflation.

Powell noted that the latest economic data indicated that the regulator would have to push benchmark interest rates higher than previously expected to temper inflation levels. Speaking to U.S. lawmakers, Powell said that the Fed would need to take tougher measures to control inflation in the country.

Powell’s hawkish comments outweighed expectations of copper demand from China, one of the biggest consumers of the red metal, causing three-month copper prices at the London Metal Exchange to dip to $8,750 per ton. The Fed chair’s remarks also caused the greenback’s value to soar to a three-month high and reduced demand for dollar-backed commodities among nondollar holders.

The Shanghai Futures Exchange  saw its most traded April copper contract drop by 1% to reach $9,875 (68,870 yuan) per ton. A Shanghai-based futures trader noted that while the reduced prices created buy-in opportunities, the exchange still had an optimistic view of China’s copper demand.

Copper is one of the most widely used metals globally. It has applications in transportation, construction and power generation, in addition to its important role in the transition to clean energy.

As China recovers from the recent lockdowns and steps up its manufacturing efforts, demand for copper is expected to pick up. Coupled with a relatively stable real estate sector, players in the copper market see moderate growth in demand in 2023. China’s ministry of housing revealed last week during an annual parliament meeting that January and February saw the end of 13 months of reductions in the sale of second-hand and new commercial property.

Powell’s remarks also caused several other base metals to stumble.

Aluminum went down by 0.9% to $2,330 a ton, zinc dropped by 1.1% to $2,922, tin reduced by 1.9% to $23,730, and lead went down by 0.6% to trade at $2,075.

At the Shanghai Metals Market, zinc prices declined by 0.7% to 23,260 yuan ($3,341) per ton, nickel dropped by 1.4% to 186,830 yuan ($26,840), aluminum dipped 0.5% to 18,540 yuan ($2,663), and tin went down 1.2% to 197,140 yuan ($28,321).

Major players in the copper space, such as Southern Copper Corporation (NYSE: SCCO), are likely to keep a close eye on the Fed’s actions over the coming months so that any impacts on the commodities market are factored into any plans they make moving forward.

Southern Copper Corporation (SCCO), closed Wednesday's trading session at $68.06, off by 7.7903%, on 2,421,598 volume. The average volume for the last 3 months is 1.529M and the stock's 52-week low/high is $42.42/$79.315.

Bit Digital Inc. (BTBT)

QualityStocks, MarketClub Analysis, StocksEarning, Schaeffer's, TradersPro, InvestorPlace, StockEarnings, MarketBeat and Daily Trade Alert reported earlier on Bit Digital Inc. (BTBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Brazil’s central bank’s maiden blockchain project, the digital real, made an entry through a public blockchain. A local paper, “Valor Economico,” stated that the trial project was done by Mercado Bitcoin, a crypto exchange, and Stellar protocol, and was designed to bring awareness to low-cost as well as real-time settlements to the users. Special attention was placed on the simulated delivery vs. payment model for the instant exchange of assets plus funds.

Fulvio Xavier, head of special projects at Mercado Bitcoin, said the thesis was geared at proving the possibility of safety and viability in transacting using digital assets leveraging public networks. He also said that the Brazilian central bank has always been concerned about what happens when transactions exit their hands.

A recent study has shown that consolidating a tokenized system of Brazil’s payment system using decentralized finance could be possible. Stellar has gone ahead and stratified specific features. The central bank of Brazil has been brooding over the use of permissioned and private blockchain in its CBDC (digital currency issued by a central bank) though recent research has indicated that public blockchains can still avail security and a myriad of extra benefits.

“Stellar is equivalent to a proxy for the regulatory agency to test run the digital real’s controls on a public/open platform,” said Roberto Durscki, Stellar’s head of partnership. Practicing on this makes piloting relatively complicated as well as successful use cases with accessibility to defi applications.

These deductions from this study will then aid the central bank of Brazil in its bid to kickstart its digital real so as to spruce up the physical currencies. A major takeaway from this research was how easy it was to onboard members with no Web3 platform or digital wallet experience nor any similarity with current rules.

CBDC Launch Inches Closer

Plans for an all-out CBDC launch in a few months, with the Brazilian central bank looking at 2024 as the launching year, are in full gear. Roberto Campos, the Brazilian central bank’s governor, affirmed that the plans initiated while 2021 was ending will greatly improve financial inclusivity.

Several financial and tech institutions have expressed partnership interest with the nation’s banking system regulator in a bid to undertake CBDC experiments. A selected few, such as Visa, Aeve, Consesys and Microsoft, have been chosen to investigate different capabilities of this digital real, especially in digital currencies through DvP, Rural financing as well as SME finance.

When institutions such as central banks begin testing reals, there is no doubt that companies such as Bit Digital Inc. (NASDAQ: BTBT) gain more confidence that the world will soon fully embrace digital currencies as a medium of exchange.

Bit Digital Inc. (BTBT), closed Wednesday's trading session at $1.18, off by 0.840336%, on 1,529,460 volume. The average volume for the last 3 months is 137,066 and the stock's 52-week low/high is $0.5301/$4.20.

Field Trip Health Ltd. (FTHWF)

We reported earlier on Field Trip Health Ltd. (FTHWF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A group of bicameral and bipartisan lawmakers has filed a revised bill that would reschedule psychedelics as breakthrough therapies and promote psychedelic research and drug development. Filed by Senators Rand Paul and Cory Booker alongside Representatives Nance Mae and Madeleine Dean, the Breakthrough Therapies Act seeks to streamline the federal process of rescheduling “breakthrough therapies” such as MDMA and psilocybin that have exhibited significant medical potential.

Thanks to a surge in psychedelic research in recent years, scientists have discovered that psychedelics have the potential to treat mental health disorders such as major depressive syndrome, anxiety and post-traumatic stress disorder.

The FDA has already approved the use of ketamine-assisted therapy for certain mental ailments and regulators are poised to grant similar approval to psilocybin (magic mushrooms) and MDMA in the near future. If the Breakthrough Therapies Act is successful, it will create a procedure that could amend the federal Controlled Substances Act and declare Schedule I drugs such as psilocybin as breakthrough therapies via the FDA.

The legislation could also make a currently controlled drug eligible for a waiver under the federal Food, Drug, and Cosmetic Act (FDCA) or transfer it to a lower schedule to reduce barriers to research and drug development. Drugs that meet any of these criteria would be moved to schedule II, which currently comprises severely restricted drugs that have “accepted medical use.”

Booker said in a public statement that certain schedule I drugs, such as psilocybin and MDMA, could significantly contribute to improvements in the treatment of PTSD, addiction and depression. He also noted that the revised bill would get rid of unsavory rules and regulations that prevent or delay scientific research into “breakthrough mental health treatments.” Furthermore, Booker noted that the bill would ensure patients who are in urgent care for mental health treatments can access psychedelic-assisted therapies.

Paul, who is also a physician, said that he was proud to partner with Booker on the psychedelics measure as it would eliminate government barriers in psychedelic research and provide patients who need medical care with compassionate care. The bipartisan pair of lawmakers first filed the bill to reschedule psychedelic breakthrough therapies and eliminate research barriers last November. The legislation would allow researchers with existing DEA schedule I and II registrations to research schedule I drugs after sending a notice to the attorney general.

It would also allow several researchers at a single institution to research schedule I drugs under one registration rather than requiring every scientist in a schedule I drug study to apply for separate registration from the DEA.

This bill is likely to be of great interest to psychedelics startups such as Field Trip Health Ltd. (OTC: FTHWF) (TSX: FTHW) since any law passed in this regard would have a direct impact on the research they are conducting on these hallucinogenic substances.

Field Trip Health Ltd. (FTHWF), closed Wednesday's trading session at $0.04, off by 18.3673%, on 137,066 volume. The average volume for the last 3 months is 937,127 and the stock's 52-week low/high is $0.0177/$0.50.

Genius Group Limited (GNS)

INO Market Report, MarketClub Analysis, The Stock Dork, QualityStocks, Schaeffer's, 247 Market News, Wall St. Warrior, Timothy Sykes, RedChip and Money Wealth Matters reported earlier on Genius Group Limited (GNS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, today announced that its redeemable discount coupons (“NFTs”) are now available for shareholders of record as of Feb. 28, 2023, to claim on Upstream’s trading app. Upon a successful claim, shareholders may redeem the NFT for iGEMs on Genius Group’s platform, GeniusU equivalent to $10 per share. “By incorporating Upstream’s Web3 digital coupons into our strategy, we aim to provide our shareholders with first-hand experience of our products, which we hope will convert them into proud customers and brand ambassadors, driving additional engagement, revenue and sales to our company,” said Genius Group CEO Roger Hamilton.

To view the full press release, visit https://ibn.fm/XUJGi

About Genius Group

Genius Group is a world-leading entrepreneur edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. The group has a user base of 4.3 million in 200 countries, ranging from ages 0 to 100. For more information, visit www.GeniusGroup.net.

Genius Group Limited (GNS), closed Wednesday's trading session at $3.15, off by 0.316456%, on 1,035,626 volume. The average volume for the last 3 months is 2,200 and the stock's 52-week low/high is $0.301/$36.7499.

The QualityStocks Company Corner

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

EverGen Infrastructure have expanded its operations to encompassorganic waste processing, through its Sea to Sky Soils facility

Sea to Sky Soils, which is operated in partnership with the Lil’watFirst Nation, processes organic material into a wide variety ofquality soils, compost and landscape material

The waste processor recently signed an agreement with a BC districtensuring the supply of over 10,000 tonnes of organic wastefeedstock per annum over the next 3 years

With EverGen playing an increasingly crucial role in furtheringCanada’s net zero ambitions, the company’s CEO Chase Edgelow wasrecently recognized in The Global and Mail’s annual list of 50Changemakers

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), has long operated at the forefront of Canada’s renewable naturalgas (“RNG”) industry. Whilst relatively nascent in nature, therenewable natural gas sector – comprising of processed biogassourced from landfills, dairy farms and organic waste, hasexperienced tremendous growth in recent years with productionfacilities increasingly being rolled out across the U.S. andCanada. In 2021 alone, RNG production capacity in the United Statesswelled to approximately 660 million gallons gasoline equivalents(“GGE”), a 20 percent increase relative to the prior year. Sincecommencing operations 12 years ago, EverGen has been an activeparticipant in the sector’s exponential growth trajectory. Boasting4 revenue generating assets already in operation, the company hasrecently announced plans to grow its cumulative gross RNGgenerating capacity to 480,000 gigajoules of energy per annum inthe near future, a process which could grow the company’s EBITDA byupwards of 300 percent (https://ibn.fm/Elrfi).

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Wednesday's trading session at $2.615, even for the day. The average volume for the last 3 months is - and the stock's 52-week low/high is $1.365/$4.00.

Recent News

Coyuchi Inc.

The QualityStocks Daily Newsletter would like to spotlight Coyuchi Inc.

Coyuchi, the gold standard in sustainable luxury home goods, is entering anew phase of growth in the wake of the increasing investment insustainability at scale. “As a company that has built its brandaround offering sustainably produced luxury organic bedding,sheets, towels, apparel, and other home goods for theenvironmentally conscious home, Coyuchi has not only pushed thesustainability conversation forward but also lived it through itsoperations. The company’s unique market positioning has seen itsnet income grow by 26% year-over-year between 2020 and 2021, with areturn customer rate of 35% over 24 months. According to itsmanagement, this was contributed mainly by the company’s commitmentto sustainability, being vocal about it, and actively bringing itsproducts closer to the consumers, as evidenced by the opening ofthe second retail location in Palo Alto, California,” a recentarticle reads. “Coyuchi’s management is optimistic that 2023 willbe a great year for the company. It is confident that thefoundation laid down so far will contribute to its growth, with oneof the key areas to be explored being partnerships with retailers.”

To view the full article, visit https://ibn.fm/QRM6m

Coyuchi is the gold standard in sustainable luxury home goods. The company offers sustainably produced luxury organic bedding, sheets, towels, apparel, and other home goods for the environmentally conscious home. With a timeless, coastal-inspired aesthetic, Coyuchi uses only 100% organic cotton materials to manufacture all of its textiles.

The Company was built upon four foundational pillars: protect the planet, innovate circular design, live sustainably, and enrich the community. These guiding principles have proven an effective market strategy. In 2021, Coyuchi earned $33.3 million in net sales, amounting to 26% YoY growth (the industry average is only 5%). It also experienced 2x customer growth to 200,000 active customers, averaging a 35% customer repeat purchase rate.

With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base that drives the fast-growing organic luxury market, Coyuchi is prepared to propel a new phase of growth as the rest of the world finally awakens to sustainability at scale.

A Lucrative Market Ripe for the Taking

The global market for organic bedding, which was estimated at $814.3 million in 2020, is projected to reach $1.1 billion by 2027, growing at a CAGR of 4.9% over that period, according to Research and Markets. More specifically, the domestic organic bedding market is estimated at $240.1 million in 2020, according to Statista. Overall, the U.S. market for home textiles is currently valued at $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025.

Grand View Research reported in 2020 that shifting consumer preference toward high-end lifestyle products is a key factor driving the growth of the organic bedding market. Seventy-four percent of consumers are willing to pay more for sustainable products – a consumer preference that has steadily increased over the last few decades. Millennials especially favor ethical consumption over price when purchasing goods and services, with 83% of millennials reporting that they want the brands they purchase from to align with their beliefs and values (https://ibn.fm/PANNV). With a majority millennial customer base, Coyuchi is poised to capitalize on this trend.

Industry Defining Sustainability Practices

For 30 years, Coyuchi has explored organic farming and sustainable textiles and guarantees the highest environmental and ethical standards through a number of certifications such as The Global Organic Textile Standard (GOTS), Fair Trade Certified, and MADE SAFE®.

Coyuchi continues to push the organic textile market forward through its circularity initiatives and by supporting cross-industry sustainability advocates. Coyuchi’s mission to bring beauty and comfort to every home without sacrificing the health of our planet has resulted in a number of important sustainability checks and balances.

  • A Circular Business Model: Coyuchi has cultivated a holistic 360-degree approach that contributes to the fight against climate change with its take back and recycling program, 2nd Home™. In 2017, it became the first luxury home brand to implement such an initiative, and, since then, the company has eliminated 68,758 lbs. of toxic chemicals from homes and renewed 6,000 lbs. of textiles.
  • The Coyuchi Climate Council: In early 2022, Coyuchi introduced a cross-disciplinary council with a goal of Net Zero Emissions by 2025 and Net Positive Emissions by 2030. The Coyuchi Climate Council brings together influential minds across fashion, regenerative farming, and sustainability who have the knowledge and experience necessary to achieve climate change.
  • C4: The California Cotton & Climate Coalition: Most recently, Coyuchi announced it is a founding member of C4, which includes innovative, sustainable fashion, apparel, and personal care brands like MATE the Label, Outerknown, Reformation, and Trace. Working together pre-competitively, C4 creates a structure for investing in regionally grown, Climate Beneficial™ cotton and directly supports the livelihoods of the farmers that grew it. Coyuchi is the only home industry brand currently involved in the project.

Omnichannel Business Model

Coyuchi differentiates itself through an omnichannel and circular business model, both of which have proven a clear draw for customers. It was an early adopter of an e-commerce sales and marketing approach (over 80% of its sales are directly through coyuchi.com), creating a distinct advantage over incumbents and start-up newcomers in the luxury space. This has resulted in a high lifetime value customer, luxury retail partners such as Nordstrom, and a flagship store in Marin County.

Coyuchi’s Organic Textile Products

Coyuchi’s product assortment consists of consciously designed bedding, bath, apparel, and lifestyle products spread across about 1,400 SKUs. The company believes that its product assortment, produced from 100% organic cotton with Global Organic Textile Standard (GOTS) certification, provides it with a significant competitive advantage. GOTS is the world’s leading textile processing standard for organic fibers, ensuring the organic status of textiles after harvesting raw materials through environmentally and socially responsible manufacturing all the way to labeling, a major environmental and social benefit over conventional cotton product production.

Coyuchi’s focused product assortment consists of four core categories:

  • Bedding – A full suite of sustainable, organic, and high-quality sheets, duvet covers, blankets, and throws.
  • Bath – A luxurious line of towels, bath rugs, and mats.
  • Apparel – Premium apparel for men and women, including robes, sweaters, pants, and pajamas.
  • Lifestyle – The lifestyle category offers 135 SKUs, from organic napkins to crossbody totes.

Management Team

Eileen Mockus is President and CEO at Coyuchi. She has more than 25 years of experience in retail, having held positions in textile development at Patagonia, Pottery Barn Teen, and The North Face. She earned a bachelor’s degree in textiles and clothing from UC Davis and an MSBA from San Francisco State University.
Sejal Solanki is Chief Marketing Officer at Coyuchi. She previously served as the company’s Vice President of E-Commerce. Before joining Coyuchi, she worked at teen clothing giant Charlotte Russe. She oversees the company’s digital marketing, site experience, brand marketing, and e-commerce strategy.

Marcus Chung is Coyuchi’s COO, overseeing supply chain, sourcing strategy, sustainability, and IT. He previously held positions at notable direct-to-consumer brands Third Love and Stitch Fix, as well as national retailer The Children’s Place. He holds a bachelor’s degree from Wesleyan University and an MBA from UC Berkeley’s Haas School of Business.

Margot Lyons is Director of Sustainability and Sourcing at Coyuchi, where she works with strategic partners to ensure all the company’s product sustainability standards are met. She received a master’s degree in textiles and clothing from UC Davis.

Use of Proceeds

This round of funding will be used to increase Coyuchi’s enterprise value through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers, and online marketplaces.

Recent News

chart

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused onmerging traditional therapeutics with psychedelic research, todayannounced that it has achieved positive results for its toxicologystudy of SP-26, its novel time-released, dosage-controlledformulation of ketamine. In collaboration with Experimur, aFrontage Laboratories company, Silo Pharma tested SP-26 in atoxicology and tolerability study in mini pigs using an ascending(descending) dosing regimen in advance of initiating clinicalstudies. “Today’s positive results are an important step as we movecloser to achieving all needed components to plan human trials ofSP-26.” said Eric Weisblum, chief executive officer of Silo Pharma.“We are advancing our work with our regulatory partners to preparea Pre-Investigational New Drug (‘IND’) package for SP-26 and intendto pursue the FDA’s streamlined 505(b)(2) regulatory pathway fordrug approval.”

To view the full press release, visit https://ibn.fm/qmLkQ

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.

Research

Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Wednesday's trading session at $1.91, off by 5.4455%, on 1,517,014 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.7401/$12.445.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources saw its corporate listing upgraded to trade on theTSX exchange as of March 6, 2023

The uplisting to the TSX main board provides the company withaccess to greater stock liquidity and increases its visibilityamongst larger institutional investors

The upgrade marks the latest feat for Eloro Resources, with thecompany having successfully completed a C$10.9mn capital raising inJanuary

Eloro Resources are aiming to publish their initial resourceestimates for their Iska Iska project by the end of 1Q 2023

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio ofgold and base-metal properties in Bolivia, Peru and Quebec,recently revealed that the company had seen its corporate listingupgraded to trade on the TSX exchange from the TSX-V market as ofMonday, March 6th, 2023. The upgrade to the TSX or Toronto StockExchange marks a significant milestone for Eloro Resources,enabling the company to access a broad array of new domestic andglobal investors which may have not previously been able to investin the stock whilst simultaneously, opening up a new financingavenue for the firm.

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.

Projects

Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Wednesday's trading session at $2.518, off by 0.474308%, on 9,908 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.09/$4.46.

Recent News

Data443 Risk Mitigation Inc. (OTC: ATDS)

The QualityStocks Daily Newsletter would like to spotlight Data443 Risk Mitigation Inc. (OTC: ATDS).

Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company, has stated itssteadfast commitment to identifying and protecting sensitiveinformation regardless of location, platform or format. “Thestatement comes at a timely juncture, as the ransomware landscapeaccelerates the rate at which most businesses are adopting datasecurity solutions and protection has become a global priority,” arecent article reads. “Data443 has looked to cater to the needs ofan increasing data security-conscious corporate sector through itsextensive product suite offering, which boasts a range of solutionsdesigned to securely manage data and data privacy needson-premises, in the cloud and in hybrid environments. Some of thekey elements included within its product suite include – Data Identification Manager(TM), designed to inventory all data repositories automatically; Data Placement Manager(TM), enabling the secure transfer of sensitive data across public andprivate networks; Data Archive Manager, a purpose-built tool facilitating information archiving andretention; Data Hound for Collaboration, a data discovery, classification and capture toolset; as well as Ransomware Recovery Manager(TM), an industry-leading solution that can assist users targeted by ahack to recover their device, operating systems and data with asimple reboot… Boasting an array of services, including anindustry-leading antivirus product and a proprietaryanti-ransomware system, Data443 is ideally positioned to benefitfrom increased online turmoil and rising demand for its productoffering.”

To view the full article, visit https://ibn.fm/D6lkV

Data443 Risk Mitigation Inc. (OTC: ATDS) is a data security and privacy software company for ALL THINGS DATA SECURITY™. The company is committed to organizing the world’s information by identifying and protecting all sensitive data regardless of location, platform or format.

Data443 provides software and services to enable secure data across devices and databases – at rest and in transit – locally, on a network, or in the cloud. With over 10,000 customers in more than 100 countries, Data443 provides a modern approach to data governance and security. The company’s framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies.

Data443 derives revenue primarily from contracts for subscriptions to access its SaaS platforms, and ancillary services provided in connection with its subscription services. In today’s ever-changing environment with unique and complex requirements for data privacy, governance and hybrid workforces, every organization needs to know where all their data is, who has access to it and how sensitive it is. Data443 provides the tools needed to give companies control over their data processing activities, with capabilities for identifying, reporting and migrating or deleting sensitive data.

The company is headquartered in Research Triangle Park, North Carolina.

Products

Focused on data security with a privacy-forward methodology, the Data443 product suite delivers solutions designed to securely manage data and data privacy needs on-premises, in the cloud and in hybrid environments. Offerings include:

  • Data Identification Manager reduces risk by shining a light on dark data across cloud, on-premises and hybrid environments. From a centralized dashboard, Data Identification Manager provides the ability to automatically inventory all data repositories, classify and tag all data, and enable global search and discovery – all through an agentless deployment.
  • Data Placement Manager quickly and securely transfers sensitive data over any public or private network. Available as an HP Nonstop server-based application and for Windows, Linux or any public cloud provider, Data Placement Manager enables the scheduling, routing, formatting and transfer of business-critical data.
  • Data Archive Manager is an “all information, anywhere” archiving solution designed to handle and manage all types of privacy requests across cloud, on-premises and hybrid environments. With over 15 years operational history and hundreds of clients managing millions of mailboxes, the platform is purpose-built for information archiving, retention and privacy request management.
  • Data Hound™ is a data discovery, classification and capture toolset that enables organizations to perform quick scans, detailed reporting and subsequent data actions based on policy.
  • Ransomware Recovery Manager is the only industry solution that actively recovers the device, operating system and data with a simple reboot. Using patented, proven technology, the product produces 100% effectiveness for the whole device and datasets.
  • Access Control Manager provides user ID and passwordless access to quickly enable trust across an organization’s entire ecosystem. Its unique architecture allows it to leverage multiple distributed authoritative sources to understand and resolve a typical access request – with the ability to enable or deny the action on the fly.
  • Global Privacy Manager provides organizations one comprehensive view, for all privacy requirements, across all enterprise data, all at once. This unmatched visibility into an organization’s data assets ensures that all private and sensitive data can be identified and protected and that enterprises can obey all relevant privacy laws in any jurisdiction.
  • Sensitive Content Manager is a security-centric collaboration service designed to give organizations the tools needed for successful content sharing, collaboration and safe distribution with full enterprise management in mind. With a continuous sync feature, encrypted data is automatically downloaded and updated in real time – regardless of location – ensuring that users have the most accurate data available.

Market Outlook

A report from Allied Market Research estimates that the global data security market was worth about $19 billion in 2021 and is projected to reach a value of $54.23 billion by 2027. That represents a CAGR of more than 18% for the forecast period, making data security one of the hottest areas within IT.

Separately, Fortune Business Insights estimates the global data privacy software market is valued at $2.36 billion in 2022 and projects it will grow to $25.85 billion by 2029. That represents a CAGR of 40.8% over the forecast period.

Management Team

Jason Remillard is President, CEO and Founder of Data443. He is responsible for overseeing global expansion, management, execution and corporate development. With over 25 years in global enterprise and B2C software sales and marketing, he brings deep leadership and technical experience, having spent previous time at Fortune 500 companies such as Deutsche Bank, TD Bank, IBM & Merrill Lynch.

Greg McCraw is CFO at Data443. He has over 25 years of experience helping businesses strengthen their accounting and finance operations. He previously served as Vice President of Finance for a dental services organization active in acquisitions, and, prior to that, he was managing director of a boutique accounting and finance consulting firm advising Fortune 500 clients in pharmaceutical, financial services, and private equity sectors on how to execute on regulatory and compliance solutions.

Bennett Pursell is Data443’s Chief Technology Officer. He has over 20 years of experience in IT architecture, security governance and systems integration. Prior to his role at Data443, he served as Head of Technology Architecture at Moody’s Investor Services and was Vice President and Technical Architect of Cloud Computing at Deutsche Bank, along with a host of technical and project management roles dating back to 2006, after starting his career as a web developer with a few startups and running research labs.

Kirill Kashigin is Chief Software Architect at Data443. He leads the development and quality teams, and serves as technical adviser and subject matter expert, bringing vast technical knowledge on privacy management and data security. Formerly the CTO of FileFacets, he has nearly 20 years in development of high-performance systems and deployment.

Data443 Risk Mitigation Inc. (OTC: ATDS), closed Wednesday's trading session at $0.04, off by 4.7619%, on 46,756 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.025/$6.99.

Recent News

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF)

The QualityStocks Daily Newsletter would like to spotlight Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF).

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) is reporting on robust nickel recovers from the initialmetallurgical test conducted on a sample from the Reid property.Based on the report, the test at Reid delivered the highest-gradenickel sulphide concentrate achieved by Canada Nickel thus far;results also indicated an overall nickel recovery of 63% with halfof recovered nickel reporting to nickel sulphide concentrategrading 60%. According to the announcement, the test used the samemineral processing flowsheet designed for the company's flagshipCrawford Nickel Sulphide project, which is located about 15kilometers from the Reid project. Canada Nickel also announce thatit closed on the acquisition of a 100% interest in the Texmontproperty, which includes 14 mining leases; the property is situatedbetween CNIKF’s Deloro and Sothman properties south of Timmins,Ontario. “We are very pleased by this first test at Reid, whichachieved an overall nickel recovery of 63% and achieved expected orbetter than expected nickel, iron, and chromium concentrategrades,” said Canada Nickel chair and CEO Mark Selby in the pressrelease. “While it is early days at Reid, these results, achievedusing the standard flowsheet developed for Crawford, demonstratethe potential to leverage our development work at Crawford, acrossthe portfolio of targets throughout our entire Timmins NickelDistrict. I am also very pleased to announce that we have closedthe acquisition of the Texmont property, where our recentlyannounced drill results support the potential for near-term,smaller scale, open pit production.”

To view the full press release, visit https://ibn.fm/mGaPO

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) is advancing the next generation of nickel-cobalt sulfide projects to deliver the metals needed to power the electric vehicle (EV) revolution and feed the high growth stainless steel market. The company is one of only a few new sources of potential supply outside Indonesia and China.

Canada Nickel possesses industry leading nickel expertise and is focused on low risk, well established mining jurisdictions. The company has launched wholly owned subsidiary NetZero Metals Inc. to develop zero-carbon production of nickel, cobalt and iron and has applied in multiple jurisdictions to trademark the terms NetZero Nickel, NetZero Cobalt and NetZero Iron. Canada Nickel is also pursuing development of processes to allow net zero carbon production of these elements.

Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulfide Project with large-scale potential located in the heart of Ontario’s prolific Timmins-Cochrane mining camp, adjacent to major infrastructure.

The company believes the EV industry and many other consumer sectors have an urgent need for zero-carbon metal this decade, not in 20-25 years as contemplated by some resource companies. Canada Nickel also believes that nickel supplies from Indonesia and other Pacific island nations, typically controlled by Chinese-owned companies, are not the answer for batteries needed by GM, Ford and the European automakers working to develop and manufacture EV models.

The company is headquartered in Toronto.

Crawford Nickel-Cobalt Sulfide Project

The Crawford Nickel-Cobalt Sulfide Project is the largest sulfide discovery since the early 1970s and contains the fifth-largest nickel sulfide resource in the world, based on Measured & Indicated resources, according to the latest update. The Crawford project is expected to be one of the largest base metal mines in Canada based on results of a Preliminary Economic Assessment. Early projections by Canada Nickel estimate that the project has the potential to produce 50,000 tons of nickel per year. The company is now in the final stages of completing the project’s feasibility study.

The project is projected to produce 2.8 tons of CO2 per ton of nickel equivalent production, which is 89% lower than the industry average of 34 tons of CO2 per ton of nickel equivalent production.

The company is taking significant steps toward developing the Crawford project as a net zero carbon producer. In addition to harnessing the natural ability of the project’s geology to act as a carbon sink through spontaneous reaction of the host rock once exposed to atmospheric conditions called mineral carbonation, Canada Nickel has discovered a new way to enhance carbon capture, termed In Process Tailings (IPT) Carbonation. This act of conditioning the tailings with a concentrated stream of carbon dioxide before deposition has been demonstrated at lab scale to achieve carbon capture at a rate 8-12 times faster than naturally occurring sequestration, achieving more than 60% of the capture that had previously taken six days.

These latest results move the company further toward production of Net Zero Nickel™ and generation of 21 tonnes of CO2 credits per tonne of nickel, which would produce an estimated average of 710,000 tonnes of CO2 credits annually and 18 million total tonnes of CO2 credits over the expected life of mine. IPT Carbonation does not require complex new technologies and major process modifications and could encourage the development of a net zero carbon industrial cluster centered around the Crawford project.

Canada Nickel in January 2023 announced that its latest test work results support the incorporation of carbon capture and storage into the Crawford project. The company believes that utilization of existing process streams should allow IPT to be efficiently engineered and incorporated into the project’s flowsheet, with an integrated feasibility study for the project expected in the second quarter of 2023.

In December 2022, Canada Nickel announced its engagement on Deutsche Bank Securities Inc. (“Deutsche Bank”) and Scotiabank – two of the world’s leading investment banks with a broad base of mining and industrial expertise – as financial advisors for the equity component of the project financing for the Crawford project. In the same release, the company announced the completion of another significant permitting milestone by filing the detailed project description with the Impact Assessment Agency of Canada. Canada Nickel targets receipt of permits by mid-2025, with construction to immediately follow.

Additional Projects

The Reid Nickel Property is located just 16 kilometers southwest of Crawford, or 37 kilometers northwest of Timmins, and contains an ultramafic body with a target geophysical footprint of 3.9 square kilometers. Preliminary assay results from Canada Nickel’s summer/fall drilling program confirm the presence of mineralized dunite, as well as currently undefined higher-grade sections. Partial assay results confirm expected nickel grades. Nickel mineralization in serpentinized dunite was found in all 16 holes drilled to date.

The Sothman Nickel Property is located 70 kilometers south of Timmins. Five drill holes on the eastern half of the target anomaly confirmed the continuation of ultramafic lithologies, primarily peridotite, with moderate to strong serpentinization and variable amounts of mineralization throughout.

The company in December 2022 announced positive drilling results from its ongoing regional exploration campaign at its Reid and Sothman properties. These latest results continue to reinforce the success of Canada Nickel’s geophysical targeting approach and increase the probability of success at the company’s other 20-plus properties within its 42 square kilometers of geophysical targets.

Building on this momentum, Canada Nickel in December 2022 announced its entry into a deal to acquire a 100% interest in the past producing Texmont property situated between the company’s properties south of Timmins. As noted in the news release, the acquisition of the Texmont property provides near-term smaller scale production potential and is highly complementary to the company’s large-scale Crawford and regional nickel sulphide projects.

Market Opportunity

Global demand leaves the market fundamentally short of nickel in the medium- and long-term. Global primary nickel demand will likely reach 3 million tons in 2022, up from 2.4 million tons in 2020, according to the International Nickel Study Group (INSG).

The INSG says primary nickel production is forecast to hit 3.1 million tons in 2022. Indonesia, the world’s largest nickel miner, halted exports of unprocessed nickel ore in January 2020, due to a government-imposed ban. Indonesia has floated the concept of a nickel cartel whose member nations would exert influence over world nickel supply and prices, similar to OPEC’s pricing power over oil.

Benchmark Minerals, a leading EV supply chain research firm, projects that, by 2035, world demand for nickel will double from current levels to 6 million tons annually. That growing demand represents a need for new nickel production equivalent to 70 mines the size of Canada Nickel’s Crawford Project.

Management Team

Mark Selby is Chairman, CEO and Director of Canada Nickel. He was formerly President and CEO of RNC Minerals, where he led a team that successfully raised over $100 million and advanced the Dumont nickel-cobalt project from initial resource to a fully permitted, construction-ready project. He has held senior management roles with Quadra Mining, Inco and Purolator Courier, and was a partner at Mercer Management Consulting. Since 2001, he has been recognized as one of the leading authorities on the nickel market. He graduated from Queen’s University with a Bachelor of Commerce.

Wendy Kaufman is CFO of Canada Nickel. She has 25 years of experience leading publicly listed mining companies in project financing, capital structuring, capital markets, accounting and internal controls, tax, and financial reporting and public disclosure. She was also previously CFO at Khiron Life Sciences Corp. and held CFO and senior finance positions at Pasinex Resources Limited, Primero Mining Corporation and Inmet Mining Corporation. She holds a Bachelor of Business Administration from Wilfrid Laurier University and is a Chartered Professional Accountant.

Steve Balch is VP Exploration at Canada Nickel. He is an Ontario registered geoscientist with 32 years of experience in geophysics, specializing in magnetic and electromagnetic methods. He founded Triumph Instruments and developed the AirTEM system, a multi-coil helicopter-borne EM system that is in use worldwide. He has also been active in borehole geophysics and helped develop new technologies including north-seeking gyros, temperature compensated induction conductivity probes, UAV-based magnetometers and high sensitivity magnetic gradiometers.

Christian Brousseau is VP Capital Projects at Canada Nickel. He is a professional engineer (P.Eng) with over 30 years of experience in engineering, design and construction in the Canadian mining industry, including six years as Project Director for the Dumont Project and three years as the Engineering and Construction Manager for Detour Gold. Prior to Detour, he held various construction management positions at Osisko’s Malartic Project and at Goldcorp’s Éléonore Project. He also spent eight years at Falconbridge supervising and managing various capital projects.

Canada Nickel Company Inc. (OTCQX: CNIKF), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company engaged in the separation and scalable production ofrare earth metals (“REE”) in the U.S. and Canada, is focused onproviding best-in-class metal separation products and services tothe mining and mineral extraction industries. “To date, China hasbeen the dominant leader in providing REE for industries, resultingin dangerous industrial leverage spanning military assets, electricvehicles, wind power generation, as well as mobile phones andothers. However, with the rising tensions between the U.S. andChina, Ucore is now positioned to create a North American REEsupply chain, allowing the U.S. to become self-sustainable in theindustry,” a recent article explains. “Acquired in 2020 by Ucore,Innovation Metals Corp. developed the RapidSX(TM) separationtechnology platform with early-stage assistance from the UnitedStates Department of Defense, which has resulted in the productionof commercial-grade, separated REE at a pilot scale. RapidSX(TM)combines the time-proven chemistry of conventional solventextraction (“SX”) with a new column-based platform thatsignificantly reduces time to completion and plant footprint, andpotentially lowers the capital required and operational costs. SXis the commercial separation technology standard for theinternational REE industry and is currently used by all REEproducers worldwide for bulk commercial separation of both heavyand light REE.”

To view the full article, visit https://ibn.fm/6FU8f

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is engaged in Rare Earth Element (REE) resource development and in commercializing its critical metals separation technology, RapidSX™, for the mining and metals extraction industry. The company is guided by principles of environmental, social and corporate governance (ESG) with a focus on disrupting China’s current dominance of the U.S. REE supply chain.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. It plans to aid in the development, through strategic partnerships, of a North American REE supply chain controlled by the U.S. and its allies.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Wednesday's trading session at $0.87, off by 8.1794%, on 58,865 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.40/$1.15.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

When Magnus Korpas, who lives in Trondheim, purchased a fully electric vehicle for thefirst time in 2019, he decided on a Tesla since there were multiplecharging points nearby at that particular time. However, thegovernment in Norway intervened fast to guarantee that chargingstations were accessible and evenly distributed. In 2011, it hadspent €7 million ($7.47 million) to install 1,900 chargingstations.

Unsurprisingly, the professor noted that electric vehicles are afairly common sight in Norway nowadays.

For three years now, Norway has steadfastly worked to transitionits fleet to electricity by encouraging customers to purchaseelectric vehicles through a combination of infrastructuralimprovements, incentives and laws. This has resulted in 20% electric vehicle prevalence on Norway’s roads.

Norway then became the first nation in the world where sales ofelectric vehicles started to surpass those of conventionalvehicles. As of now, electric vehicles make up about 80% of newautomobile sales in Norway. When different markets and countriessuccessfully implement some of the strategies that have made Norwaya role model in EV adoption, startups such as Mullen Automotive Inc. (NASDAQ: MULN) could see their sales climbing steeply as demand skyrockets.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $0.1489, off by 4.4901%, on 309,904,537 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.13/$4.1799.

Recent News

Aditxt Inc. (NASDAQ: ADTX)

The QualityStocks Daily Newsletter would like to spotlight Aditxt Inc. (NASDAQ: ADTX).

There is a critical shortage of organs within the organ transplant field. Even though there are more than 100,000 people awaiting organ transplants in the United States, there were only 14,903 deceased organ donors last year. The organ shortage crisis in the U.S. and across the globe istaking thousands of lives each year. In the U.S. alone, 13 patientslose their lives to severe kidney disease every day while awaitinga compatible kidney.

With around 92,000 people waiting for an organ transplant this year, 1 in 10 of them willhave quite a hard time securing a compatible kidney. On top of theorgan shortage, these patients face the risk of organ rejectionafter receiving a compatible organ.

Reviews of blood from kidney disease patients have revealed thepresence of antibodies that are likely to attack any organ such apatient receives.

Fred Hutchinson Cancer Center’s Joshua Hill, MD, notes that havingantibodies against potential donors is one of the primary mechanisms behind organ rejection. He said that patients with such antibodies could not receive mostof the available organs and are forced to stay on the waiting listfor a long time, which significantly increases their chances of dying.Other efforts are being directed by companies such as Aditxt Inc. (NASDAQ: ADTX) toward tweaking the immune system so that the likelihood of adonated organ being rejected is minimized.

Aditxt Inc. (NASDAQ: ADTX) is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. Aditxt’s immune mapping technologies are designed to provide a personalized immune profile. Aditxt’s immune reprogramming technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.

As further discussed below, the company’s first commercial product is an immune mapping technology, AditxtScore™, which is designed to provide a personalized profile of the immune system.

The company’s preclinical immune reprogramming technology, Apoptotic DNA Immunotherapy™ (“ADi™”), aims to retrain the immune system to induce tolerance, with the goal of addressing vast unmet needs in transplanted organ rejection, autoimmune diseases, and allergies. The company is developing specific ADi™ products for psoriasis, type 1 diabetes, and skin grafting.

Headquartered in Richmond, Virginia, Aditxt also operates locations in Silicon Valley and New York.

AditxtScore™

AditxtScore™ is a proprietary platform designed to provide a personalized, comprehensive profile of an individual’s immune system. The underlying technology, licensed from Stanford University through an exclusive worldwide agreement, offers a highly sensitive and accurate method of detecting and quantifying cellular responses, allowing greater specificity, quantification, and amplification of both clinical and commercial opportunities.

The company’s first commercial application of the platform, AditxtScore™ for COVID-19, delivers timely reports on vulnerability and immune status relating to SARS-CoV-2 and its known variants, giving consumers and physicians the data needed to make informed health decisions. Potential future applications will offer early detection of an array of conditions, including diabetes, cardio-metabolic maladies and hormonal imbalances.

Aditxt’s AditxtScore™ immune monitoring center in Richmond, Virginia, is operational and designed to support the anticipated increased demand for AditxtScore™ as well as related products and services. The company is currently scaling its capabilities at this location, with a goal of processing up to 10 million immune system tests/reports annually.

ADi™

ADi™ is Aditxt’s immune reprogramming platform addressing disease-causing immune responses while maintaining the immune system’s ability to combat pathogenic infection. The company is commercializing a nucleic acid-based technology called Apoptotic DNA Immunotherapy™ (ADi™) which utilizes a novel approach that mimics the way our bodies naturally induce tolerance to our own tissues (therapeutically induced immune tolerance). Aditxt believes its ADi™ technology platform can be engineered to address a wide variety of indications.

Aditxt is currently developing ADi™ products for psoriasis, type 1 diabetes and skin grafting.

Currently, immuno-tolerance is achievable through chimerism and cell-based therapy, but there is a clinical need for a more practical and cost-effective approach which:

  • Can be made into a product
  • Does not require additional hospitalization
  • Is simple to produce and ship

Preclinical studies have demonstrated that ADi™ treatment significantly and substantially prolongs graft survival, in addition to successfully “reversing” other established immune-mediated inflammatory processes. ADi™ treatment is not expected to require hospitalization, instead being delivered as an injection in minute amounts into the skin.

IP Portfolio

Both AditxtScore™ and ADi™ are supported by a strong IP portfolio.

AditxtScore™, built upon initial technology invented, licensed from and used at Stanford University, is protected by U.S. patents encompassing methods, systems, and kits for detection and measurement of specific immune responses.

ADi™ technology is protected by seven patent families, including:

  • 8 U.S. patents
  • 4 pending U.S. patent applications
  • 86 foreign patents and 14 pending foreign patent applications spanning the EU, Australia, Canada, Japan, China, India and Hong Kong

These patents are broadly categorized into three groups:

  • Autoimmune diseases and Type 1 Diabetes
  • Organ transplantation and a method of producing plasmid DNA to prevent immune activation
  • Composition of matter for a tolerance delivery system for antigens of interest

Aditxt also possesses and/or in-licenses substantial know-how and trade secrets relating to the development and commercialization of its product candidates, including related manufacturing processes and technologies.

Market Overview

The potential market opportunities presented by immune monitoring and reprogramming are extensive, particularly as Aditxt continues to evaluate additional applications for the platforms.

The company’s initial focus on organ transplantation and related autoimmune response provides some insight into the potential of its approach. According to BCC Research, the global organ and tissue transplantation and alternatives market is on course to reach $120.3 billion by 2024, recording a CAGR of 7.4% from 2019. Industry data suggest that approximately 50% of all transplanted organs are rejected within 10-12 years, further highlighting the critical need for a practical, cost-effective solution to harmful autoimmune responses.

Through its focus on the COVID-19 testing market with AditxtScore™, Aditxt demonstrated the wide-ranging potential of its portfolio. Fortune Business Insights estimated the global COVID-19 diagnostics market at $48.64 billion for 2022. While demand for COVID-19 diagnostics is expected to lessen in the coming years, Aditxt will be uniquely positioned to leverage its existing infrastructure stemming from these operations as the company works to advance broader applications for the AditxtScore™ platform.

Leadership Team

Amro Albanna is the Co-Founder, Chairman, and CEO of Aditxt. He has founded multiple startups to commercialize innovations in various industries, including healthcare, enterprise software, telecommunications, nano technology, consumer health, and biotech. Mr. Albanna has led numerous M&A and going-public transactions as a founder, co-founder, and senior executive.

Shahrokh Shabahang, D.D.S., MS, Ph.D., is the company’s Co-Founder, Chief Innovation Officer, and a member of its board. He brings to the team more than 20 years of experience in developing and commercializing life science technologies focused on product and clinical development in the fields of microbiology and immunology.

Corinne Pankovcin, CPA, MBA, is the President of Aditxt. Prior to joining Aditxt, Ms. Pankovcin served as CFO for several world class organizations, including Business Development Corporation of America, Blackrock Kelso Capital and AIG Capital Partners. In these roles, Ms. Pankovcin was responsible for executing portfolio investments and managing significant M&A transactions.

Thomas Farley is the Chief Financial Officer of Aditxt. From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant.

Rowena Albanna is the company’s Chief Operating Officer. Ms. Albanna has over two decades of experience in senior leadership roles for both technology startups and public companies. Ms. Albanna’s experience spans a wide variety of industries, including biotechnology, insect control, nanotechnology, consumer electronics, financials, telecommunications, e-commerce, online marketing, medical, and defense.

Matthew Shatzkes is the Chief Legal Officer and General Counsel of Aditxt. As a former partner at an AM Law 50 law firm, Mr. Shatzkes advised a wide variety of healthcare related entities, including biotech companies, on corporate, regulatory, and strategic business matters. Mr. Shatzkes will oversee all aspects of the legal functions at Aditxt, including, providing advice and counsel on governance, regulatory matters, strategic alliances, mergers and acquisitions, and commercial transactions.


Aditxt Inc. (NASDAQ: ADTX), closed Wednesday's trading session at $1, off by 2.9126%, on 42,545 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.00/$28.49.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

Medical cannabis dispensaries have a growing selection of products for anxiety, pain, sex and other conditions, with many available strains having magicaland evocative names such as Bubba Kush, Blue Dream and Chocolope.But what exactly does this mean? Do the various strains’ medicalproperties differ from one another? Or are the creative namesmerely marketing ploys?

Cannabis is not just a source of cannabinoids, as several studieshave shown. The plants is an especially abundant source oftherapeutic substances that humans have not yet fully explored. Butto fully utilize the plant’s potential, society must move past itsprejudices against marijuana and consider what the evidenceunambiguously demonstrates about its therapeutic value.

The FDA has already taken steps in this direction by approvingprescription medications made from marijuana, such as cannabidiol(CBD), dronabinol, nabiximols and nabilone. Nabilone and dronabinolare used to treat nausea, while CBD and nabiximols, which containTHC, the psychoactive ingredient in marijuana, are used for multiple sclerosis. Startups such as India Globalization Capital Inc. (NYSE American: IGC) are looking to leverage the potential of many of thesecannabinoids in order to develop formulations that get FDA-approvedfor use in the medical system.

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule (www.clinicaltrials.gov). As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products (www.Holief.com) such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand (www.SundaySeltzer.com) that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.

IGC-AD1

IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.

TGR-63

The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Wednesday's trading session at $0.3409, off by 2.6%, on 87,592 volume. The average volume for the last 3 months is 84,644 and the stock's 52-week low/high is $0.2785/$1.16.

Recent News

Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: BMR) (OTCQB: BTRMF).

Battery Mineral Resources is focused on the discovery, acquisitionand development of battery metal projects in North America, SouthAmerica and South Korea

The company’s flagship Punitaqui mine has the potential to generatean annual EBITDA of up to $50 million at or above a copper price of$4.25/lb. with production targeted for H2 of this year

BMR is working to secure final funding for the restart of miningand resumption of copper concentrate production from its Punitaquicomplex; it in advanced discussions with several parties and hasthe goal of closing a funding agreement in the coming months

In the second half of 2022, BMI made significant progress towardincreasing and improving its human and financial resources, as wellas permitting, metallurgy and ESG initiatives

The company is strategically positioning itself to take advantageof renewed positive market sentiment for near term copper pricing

Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) is a battery minerals company providing shareholders exposure tothe global mega-trend of electrification while being focused ongrowth through cash-flow, exploration and acquisitions in favorablemining jurisdictions.

Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) is a battery minerals company providing shareholders exposure to the global mega-trend of electrification while being focused on growth through cash-flow, exploration and acquisitions in favorable mining jurisdictions.

The company’s mission is the discovery, acquisition and development of battery metals (namely copper, cobalt, lithium, and graphite) in North America, South America and South Korea. It aims to become a leading low-cost producer of high quality, ethically sourced battery metals from high-grade, low impact mines in stable jurisdictions that are close to major consumer industries.

BMR is headquartered in Vancouver, British Colombia, with a portfolio of projects spanning Canada, the U.S., Chile and South Korea.

Project Portfolio

BMR’s current focus is the restart of its Punitaqui copper mine in Chile, as well as the exploration and development of its cobalt, lithium and graphite assets in North America and South Korea. The company also continues to identify and evaluate new project opportunities in its operating jurisdictions.

Its current portfolio includes:

Chile – Copper

BMR’s 100%-owned Punitaqui copper mine, acquired in March 2021, has the potential to generate an annual EBITDA of up to $50 million at or above a copper price of $4.25/lb. The company’s flagship project, the Punitaqui mine has been the subject of numerous milestones in recent months, including:

  • BMR funded and completed a successful 32,526m resource drill program in 2022. Metallurgical testwork has confirmed the ability to produce excellent copper concentrates from each of the five zones tested, including recoveries ranging from 81% on the low end at Cinabrio Norte up to 96.5% at the Dalmacia deposit.
  • The company in August 2022 reported the results of its first ever NI 43-101-compliant resource estimate for the underground deposits at its Punitaqui copper mining complex of 6.2 million tonnes grading 1.14% Cu in indicated category, along with 3.1 million tonnes grading 0.93% Cu in the inferred category. This resource estimate greatly exceeded management goals.
  • In September 2022, BMR announced the approval by the Chilean Environment Assessment Service for the Environmental Impact Declaration (“DIA”) pertaining to mining at the company’s Cinabrio mine and San Andres deposit. The approval of the DIA allows BMR to move forward with starting mining operations in 2023 and restarting the mill at its Punitaqui copper mining complex soon after.
  • BMR is focused on securing the final funding for the restart of mining and resumption of copper concentrate production at Punitaqui. Once this funding is received, BMR aims to complete mine rehabilitation and development in four to six months, with the ramp up from first production to the full production rate of 20-25 million pounds of copper in concentrate per annum to require a further four to six months.

“From exploration, engineering, community and permitting successes to realizing several non-dilutive means of funding to allow BMR to advance the project, our team looks forward to taking advantage of the renewed positive market sentiment for near term copper pricing and placing ourselves in a strong position to participate in a robust copper sector in 2023,” CEO Martin Kostuik stated in a news release.

Canada – Cobalt/Silver

Between 2016 and April 2018, BMR acquired through claim staking, option, joint venture and direct purchase the largest regional land holding in the historic home of high-grade cobalt-silver veins in Canada known locally as the Cobalt Embayment.

As of February 2023, BMR controlled a land package totaling 9 properties with 4,086 tenements that encompass an area of 84,003.39Ha. The key projects within the land package include McAra, Gowganda, Elk Lake, Fabre and Wilder. From 2017-2022, a total of 412 holes/51,452.34m were drilled on eight projects/20 targets. In addition, a total of 26,709 Line-Km of airborne geophysical surveys & 1,324.84sqkm of LiDAR topography was flown. Follow-up ground geophysical surveys resulted in a total of 37 surveys (514.64 Line-Km) being completed.

Initial NI 43-101 compliant resource defined at McAra (M&I Resource of 1,124,000lbs Co) was detailed in a Technical Report on Cobalt Exploration Assets in Canada dated as of February 5, 2021, with an effective date of October 31, 2020, prepared by SRK Consulting – G Cole PGeo (APGO#1416).

Idaho – Cobalt

BMR holds the Bonanza and East Fork properties located in the historic cobalt-copper-gold Blackbird mining district (Blackbird Mine from 1902-1963 produced 17Mt grading 0.7% Co, 1.4% Cu, and 1 g/t Au) located about 30 kilometers west of Salmon, Idaho. The Bonanza project is immediately adjacent to Jervois Global’s Idaho Cobalt Operations, the United States’ only operating primary cobalt mine. At Bonanza, there are seven mineralized sites within an area over three kilometers wide that extends along a gabbro dyke striking continuously for over six kilometers northward from Noranda’s historic Blackbird Cobalt/Copper mine. The showings on the project are Bonanza Copper Tunnels, Tinker’s Pride, Bonanza Copper #25, Indian Creek, Gray Copper, Blackrock #4 and Papoose #’s 1-4.

From 2018-2021, BMR’s Bonanza Exploration included 550 line-km of airborne magnetics and radiometrics followed up by surface exploration that included rock sampling, soil sampling, channel sampling of historic workings and 3.6km of time domain induced polarization geophysics.

The two properties cover 12 significant cobalt-copper prospects within the known mineralized zone. Both of the BMR Idaho cobalt belt properties host excellent high-grade discovery potential.

South Korea – Graphite

BMR has 100% ownership of the Guemam and Taehwa graphite exploration projects containing high-purity flake graphite deposits. Both assets are past-producing mines with existing local infrastructure and near-term production potential.

Nevada – Lithium

The company’s Amargosa lithium project is in the southern Basin & Range province and central Mojave Desert of Nevada. It is an early-stage exploration opportunity in a favorable region that hosts numerous lithium occurrences, including the Clayton Valley lithium deposit owned by Cypress Development Corp., as well as a major nearby lithium brine mine currently in production called the Silver Peak mine held by Albermarle Corp., one of the world’s largest lithium producers.

Market Opportunity

Near-term forecasts for the copper sector are extremely bullish, with stalwart Wall Street firms such as Goldman Sachs and Bank of America projecting record highs in the coming months. A combination of short-term supply deficits and long-term energy transition demand are expected to buck the downward pressures that have impacted copper prices in recent years.

Goldman in December 2022 forecast a 178K metric ton deficit in the copper market in 2023, causing the firm to raise its 12-month target to $11K/ton and its average price for calendar 2023 to $9,750/ton.

With China likely to continue accelerating efforts to restock depleted inventories in the wake of its COVID-19 reopening and a sustained push toward electrification around the globe placing a strain on supply, BMR is uniquely positioned to capitalize through the anticipated restart of operations at its Punitaqui copper mine.

Management Team

JMartin Kostuik is CEO and a Director of BMR. He brings to the company nearly three decades of diversified experience in the mining industry as a mining engineer and senior executive. Prior to joining BMR, Mr. Kostuik served as president and director of Arizona Gold Corporation and as CEO and director of Rupert Resources Limited. He built a broad base of experience in operations, engineering, exploration and capital projects with various companies including Luna Gold (Equinox), Barrick Gold Corporation, Taseko Mines Limited and DMC Mining Services. Mr. Kostuik earned his B.S. in Mining Engineering from Queen’s University and his M.B.A. from the University of Tennessee.

JMax Satel is the company’s CFO. He has over 18 years of experience as a successful natural resources-focused executive, most recently serving as EVP Corporate Development & Investor Relations for Arrow Exploration Corp., a TSX Venture- and AIM-listed oil & gas company with operations in Colombia and Canada. Prior to joining Arrow, Mr. Satel was principal and co-founder of Bordeaux Capital Inc., a Toronto-based advisory firm focused on the capital needs of companies across the natural resources sector, where he led and executed project financing advisory mandates involving global financial institutions and private equity funds. He earned a Bachelor of Commerce in Finance and Economics from the University of Toronto.

Jacob Willoughby is VP Corporate Development & Strategy for BMR. He brings to the company nearly 17 years of diversified experience in mining capital markets, including over eight years as a mining analyst covering exploration and development companies globally in both precious and base metals. Mr. Willoughby was most recently Vice President of Research and Analyst at Red Cloud Securities in Toronto. He spent two years as President and Director of Aldridge Minerals, a former Canadian based public exploration and development company with assets in Turkey and Papua New Guinea. Mr. Willoughby earned both a B.S. in Geology and a Masters in Business Administration from the University of Windsor.

FingerMotion Inc. (BTRMF), closed Wednesday's trading session at $0.0899, off by 3.7473%, on 59,905 volume. The average volume for the last 3 months is 59,905 and the stock's 52-week low/high is $0.0355/$1.05.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, on Tuesday announced business updates and financials for thefourth quarter and full year ended Dec. 31, 2022. “We closed outour first year as a public company with notable achievements,” saidJun Pei, Cepton’s co-founder and CEO. “We are in the final stagesof preparation for the start of the production launch of our lidarfor OEM customers, we announced our next-generation Vista(R)-X120Plus lidar to meet future OEM requirements and closed the $100million investment from Koito. We look forward to capitalizing onour extensive experience in commercializing automotive grade lidarto win additional series production awards this year.”

To view the full press release, visit https://ibn.fm/eoJjP

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Wednesday's trading session at $0.54, off by 10.1049%, on 1,066,901 volume. The average volume for the last 3 months is 1.067M and the stock's 52-week low/high is $0.403/$6.02.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.